{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:06:31Z","timestamp":1789977991416,"version":"4.0.1"},"publisher-location":"Totowa, NJ","reference-count":56,"publisher":"Humana Press","isbn-type":[{"value":"9781627037266","type":"print"},{"value":"9781627037273","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T00:00:00Z","timestamp":1383177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-1-62703-727-3_20","type":"book-chapter","created":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T17:47:30Z","timestamp":1384969650000},"page":"381-393","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Melanoma Susceptibility Genes and Risk Assessment"],"prefix":"10.1007","author":[{"given":"Alexander","family":"Marzuka-Alcal\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele Jacobs","family":"Gabree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hensin","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,31]]},"reference":[{"key":"20_CR1","unstructured":"Goldstein AM, Tucker MA (2004) Familial melanoma and its management. In: Eeles R, Easton D, Eng C, Ponder B (eds) Genetic predisposition to cancer, 2nd edn. Arnold Publishers Ltd, London"},{"key":"20_CR2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng0994-22","volume":"8","author":"A Kamb","year":"1994","unstructured":"Kamb A, Shattuck-Eidens D, Eeles R et al (1994) Analysis of the p16 gene (CDKN2A) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8:23\u201326","journal-title":"Nat Genet"},{"key":"20_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","volume":"8","author":"CJ Hussussian","year":"1994","unstructured":"Hussussian CJ, Struewing JP, Goldstein AM et al (1994) Germline p16 mutations in familial melanoma. Nat Genet 8:15\u201321","journal-title":"Nat Genet"},{"key":"20_CR4","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archderm.137.11.1493","volume":"137","author":"AM Goldstein","year":"2001","unstructured":"Goldstein AM, Tucker MA (2001) Genetic epidemiology of cutaneous melanoma: a global perspective. Arch Dermatol 137:1493\u20131496","journal-title":"Arch Dermatol"},{"key":"20_CR5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2006.043802","volume":"44","author":"AM Goldstein","year":"2007","unstructured":"Goldstein AM, Chan M, Harland M et al (2007) Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet 44:99\u2013106","journal-title":"J Med Genet"},{"key":"20_CR6","first-page":"6864","volume":"60","author":"J Hashemi","year":"2000","unstructured":"Hashemi J, Platz A, Ueno T et al (2000) CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas. Cancer Res 60:6864\u20136867","journal-title":"Cancer Res"},{"key":"20_CR7","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM199803263381305","volume":"338","author":"J Monzon","year":"1998","unstructured":"Monzon J, Liu L, Brill H et al (1998) CDKN2A mutations in multiple primary melanomas. N Engl J Med 338:879\u2013887","journal-title":"N Engl J Med"},{"key":"20_CR8","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/375506a0","volume":"375","author":"J Koh","year":"1995","unstructured":"Koh J, Enders GH, Dynlacht BD et al (1995) Tumour-derived p16INK4a alleles encoding proteins defective in cell-cycle inhibition. Nature 375:506\u2013510","journal-title":"Nature"},{"key":"20_CR9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/375503a0","volume":"375","author":"J Lukas","year":"1995","unstructured":"Lukas J, Parry D, Aagaard L et al (1995) Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375:503\u2013506","journal-title":"Nature"},{"issue":"11","key":"20_CR10","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1101\/gad.191999.112","volume":"26","author":"H Tsao","year":"2012","unstructured":"Tsao H, Chin L, Garraway LA et al (2012) Melanoma: from mutations to medicine. Genes Dev 26(11):1131\u20131135","journal-title":"Genes Dev"},{"issue":"3","key":"20_CR11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.sder.2010.06.002","volume":"29","author":"D Udayakumar","year":"2010","unstructured":"Udayakumar D, Mahato B, Gabree M et al (2010) Genetic determinants of cutaneous melanoma predisposition. Semin Cutan Med Surg 29(3):190\u2013195","journal-title":"Semin Cutan Med Surg"},{"key":"20_CR12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0092-8674(00)81400-2","volume":"92","author":"J Pomerantz","year":"1998","unstructured":"Pomerantz J, Schreiber-Agus N, Liegeois NJ et al (1998) The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2\u2019s inhibition of p53. Cell 92:713\u2013723","journal-title":"Cell"},{"key":"20_CR13","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1093\/emboj\/17.17.5001","volume":"17","author":"FJ Stott","year":"1998","unstructured":"Stott FJ, Bates S, James MC et al (1998) The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 17:5001\u20135014","journal-title":"EMBO J"},{"key":"20_CR14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0092-8674(00)81401-4","volume":"92","author":"Y Zhang","year":"1998","unstructured":"Zhang Y, Xiong Y, Yarbrough WG et al (1998) ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92:725\u2013734","journal-title":"Cell"},{"key":"20_CR15","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/jnci\/94.12.894","volume":"19","author":"DT Bishop","year":"2002","unstructured":"Bishop DT, Demenais F, Goldstein AM et al (2002) Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 19:894\u2013903","journal-title":"J Natl Cancer Inst"},{"issue":"20","key":"20_CR16","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/jnci\/dji312","volume":"97","author":"CB Begg","year":"2005","unstructured":"Begg CB, Orlow I, Hummer AJ et al (2005) Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst 97(20):1507\u20131515","journal-title":"J Natl Cancer Inst"},{"key":"20_CR17","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/jnci\/89.19.1460","volume":"89","author":"DC Whiteman","year":"1997","unstructured":"Whiteman DC, Milligan A, Welch J et al (1997) Germline CDKN2A mutations in childhood melanoma. J Natl Cancer Inst 89:1460","journal-title":"J Natl Cancer Inst"},{"key":"20_CR18","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/archderm.136.9.1118","volume":"136","author":"H Tsao","year":"2000","unstructured":"Tsao H, Zhang X, Kwitkiwski K et al (2000) Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. Arch Dermatol 136:1118\u20131122","journal-title":"Arch Dermatol"},{"issue":"1","key":"20_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF03401664","volume":"3","author":"WD Foulkes","year":"1997","unstructured":"Foulkes WD, Flanders TY, Pollock PM et al (1997) The CDKN2A (p16) gene and human cancer. Mol Med 3(1):5\u201320","journal-title":"Mol Med"},{"key":"20_CR20","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.1997.03540420035026","volume":"277","author":"MA Tucker","year":"1997","unstructured":"Tucker MA, Halpern A, Holly EA et al (1997) Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 277:1439\u20131444","journal-title":"JAMA"},{"key":"20_CR21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s004390050642","volume":"101","author":"S Puig","year":"1997","unstructured":"Puig S, Ruiz A, Castel T et al (1997) Inherited susceptibility to several cancers but absence of linkage between dysplastic nevus syndrome and CDKN2A in a melanoma family with a mutation in the CDKN2A (P16INK4A) gene. Hum Genet 101:359\u2013364","journal-title":"Hum Genet"},{"key":"20_CR22","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199510123331504","volume":"333","author":"AM Goldstein","year":"1995","unstructured":"Goldstein AM, Fraser MC, Struewing JP et al (1995) Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med 333:970\u2013974","journal-title":"N Engl J Med"},{"issue":"4","key":"20_CR23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jaad.2009.03.016","volume":"61","author":"SA Leachman","year":"2009","unstructured":"Leachman SA, Carucci J, Kohlman W et al (2009) Selection criteria for genetic assessment of patients with melanoma. J Am Acad Dermatol 61(4):677","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"20_CR24","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/0008-5472.CAN-09-2653","volume":"70","author":"W Wang","year":"2010","unstructured":"Wang W, Niendorf KB, Patel D et al (2010) Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary melanoma using MelaPRO. Cancer Res 70(2):552\u2013559","journal-title":"Cancer Res"},{"issue":"6","key":"20_CR25","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1365-2133.2011.10551.x","volume":"165","author":"V Nikolaou","year":"2011","unstructured":"Nikolaou V, Kang X, Stratigos A et al (2011) Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma. Br J Dermatol 165(6):1219\u20131222","journal-title":"Br J Dermatol"},{"key":"20_CR26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0196-97","volume":"12","author":"L Zuo","year":"1996","unstructured":"Zuo L, Weger J, Yang Q et al (1996) Germline mutations in p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 12:97\u201399","journal-title":"Nat Genet"},{"key":"20_CR27","doi-asserted-by":"crossref","first-page":"8541","DOI":"10.1073\/pnas.93.16.8541","volume":"93","author":"MG Fitzgerald","year":"1996","unstructured":"Fitzgerald MG, Harkin DP, Silva-Arrieta S et al (1996) Prevalence of germline mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. Proc Natl Acad Sci 93:8541\u20138545","journal-title":"Proc Natl Acad Sci"},{"key":"20_CR28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/hmg\/7.2.209","volume":"7","author":"N Soufir","year":"1998","unstructured":"Soufir N, Avril MF, Chompret A et al (1998) Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. Hum Mol Genet 7:209\u2013216","journal-title":"Hum Mol Genet"},{"issue":"6009","key":"20_CR29","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour JW, Onken MD, Roberson ED et al (2010) Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330(6009):1410\u20131413","journal-title":"Science"},{"issue":"10","key":"20_CR30","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","volume":"43","author":"T Wiesner","year":"2011","unstructured":"Wiesner T, Obenauf AC, Murali R et al (2011) Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43(10):1018\u20131021","journal-title":"Nat Genet"},{"issue":"10","key":"20_CR31","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa JR, Cheung M, Pei J et al (2011) Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43(10):1022\u20131025","journal-title":"Nat Genet"},{"issue":"4","key":"20_CR32","doi-asserted-by":"crossref","first-page":"e35295","DOI":"10.1371\/journal.pone.0035295","volume":"7","author":"CN Njauw","year":"2012","unstructured":"Njauw CN, Kim I, Piris A et al (2012) Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One 7(4):e35295","journal-title":"PLoS One"},{"issue":"1","key":"20_CR33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1479-5876-10-179","volume":"10","author":"M Carbone","year":"2012","unstructured":"Carbone M, Korb FL, Baumann F et al (2012) BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med 10(1):179","journal-title":"J Transl Med"},{"key":"20_CR34","doi-asserted-by":"publisher","unstructured":"Wadt K, Choi J, Chung JY et al (2012) A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma. Pigment Cell Melanoma Res. doi:10.1111\/pcmr.12006","DOI":"10.1111\/pcmr.12006"},{"key":"20_CR35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","volume":"41","author":"S Gandini","year":"2005","unstructured":"Gandini S, Sera F, Cattaruzza MS et al (2005) Meta-analysis of risk factors for cutaneous melanoma. I. Common and atypical naevi. Eur J Cancer 41:28\u201344","journal-title":"Eur J Cancer"},{"key":"20_CR36","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.ejca.2005.03.034","volume":"41","author":"S Gandini","year":"2005","unstructured":"Gandini S, Sera F, Cattaruzza MS et al (2005) Meta-analysis of risk factors for cutaneous melanoma. III. Family history, actinic damage, and phenotypic factors. Eur J Cancer 41:2040\u20132059","journal-title":"Eur J Cancer"},{"issue":"1","key":"20_CR37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2133.2009.09565.x","volume":"162","author":"AJ Miller","year":"2010","unstructured":"Miller AJ, Tsao H (2010) New insights into pigmentary pathways and skin cancer. Br J Dermatol 162(1):22\u201328","journal-title":"Br J Dermatol"},{"key":"20_CR38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1195-328","volume":"11","author":"F Valverde","year":"1995","unstructured":"Valverde F, Healy E, Jackson I et al (1995) Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 11:328\u2013330","journal-title":"Nat Genet"},{"key":"20_CR39","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.0022-202x.2001.01421.x","volume":"117","author":"C Kennedy","year":"2001","unstructured":"Kennedy C, ter Huurne J, Berkhout M et al (2001) Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk of cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 117:294\u2013300","journal-title":"J Invest Dermatol"},{"key":"20_CR40","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/ijc.23396","volume":"122","author":"S Raimondi","year":"2008","unstructured":"Raimondi S, Sera F, Gandini S et al (2008) MC1R variants, melanoma, and red hair color phenotype: a meta-analysis. Int J Cancer 122:2753\u20132760","journal-title":"Int J Cancer"},{"issue":"8","key":"20_CR41","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/archderm.1994.01690080084012","volume":"130","author":"KH Kraemer","year":"1994","unstructured":"Kraemer KH, Lee MM, Andrews AD et al (1994) The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 130(8):1018\u20131021","journal-title":"Arch Dermatol"},{"key":"20_CR42","first-page":"1016","volume":"24","author":"D Mitra","year":"2011","unstructured":"Mitra D, Luo X, Wargo J et al (2011) Why red-heads are at increased risk of melanoma: a novel BRAF mutant mouse model. Pigm Cell Melanoma R 24:1016","journal-title":"Pigm Cell Melanoma R"},{"issue":"9","key":"20_CR43","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","volume":"12","author":"C Levy","year":"2006","unstructured":"Levy C, Khaled M, Fisher DE et al (2006) MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 12(9):406\u2013413","journal-title":"Trends Mol Med"},{"key":"20_CR44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature10630","volume":"480","author":"S Yokoyama","year":"2011","unstructured":"Yokoyama S, Woods S, Boyle GM et al (2011) A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature 480:99\u2013103","journal-title":"Nature"},{"key":"20_CR45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","volume":"480","author":"C Bertolotto","year":"2011","unstructured":"Bertolotto C, Lesueur F, Giuliano S et al (2011) A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 480:94\u201398","journal-title":"Nature"},{"issue":"11","key":"20_CR46","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/ng.959","volume":"43","author":"JH Barrett","year":"2011","unstructured":"Barrett JH, Iles MM, Harland M et al (2011) Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet 43(11):1108\u20131113","journal-title":"Nat Genet"},{"issue":"24","key":"20_CR47","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1093\/hmg\/ddr415","volume":"20","author":"CI Amos","year":"2011","unstructured":"Amos CI, Wang LE, Lee JE et al (2011) Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet 20(24):5012\u20135023","journal-title":"Hum Mol Genet"},{"issue":"11","key":"20_CR48","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ng.958","volume":"43","author":"S Macgregor","year":"2011","unstructured":"Macgregor S, Montgomery GW, Liu JZ et al (2011) Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. Nat Genet 43(11):1114\u20131118","journal-title":"Nat Genet"},{"issue":"8","key":"20_CR49","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ng.410","volume":"41","author":"M Falchi","year":"2009","unstructured":"Falchi M, Bataille V, Hayward NK et al (2009) Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat Genet 41(8):915\u2013919","journal-title":"Nat Genet"},{"issue":"8","key":"20_CR50","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ng.411","volume":"41","author":"DT Bishop","year":"2009","unstructured":"Bishop DT, Demenais F, Iles MM et al (2009) Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 41(8):920\u2013925","journal-title":"Nat Genet"},{"key":"20_CR51","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/jmg.2005.032441","volume":"43","author":"KB Niendorf","year":"2006","unstructured":"Niendorf KB, Goggins W, Yang G et al (2006) MELPREDICT: a logistic regression model to estimate CDKN2A carrier probability. J Med Genet 43:501\u2013506","journal-title":"J Med Genet"},{"key":"20_CR52","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2009.27.0660","volume":"28","author":"ME Robson","year":"2010","unstructured":"Robson ME, Storm CD, Weitzel J et al (2010) Policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 28:893\u2013901","journal-title":"J Clin Oncol"},{"key":"20_CR53","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(02)00894-X","volume":"3","author":"R Kefford","year":"2002","unstructured":"Kefford R, Bishop JN, Tucker M et al (2002) Genetic testing for melanoma. Lancet Oncol 3:653\u2013654","journal-title":"Lancet Oncol"},{"key":"20_CR54","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1200\/JCO.1999.17.10.3245","volume":"17","author":"RF Kefford","year":"1999","unstructured":"Kefford RF, Newton Bishop JA, Bergman W et al (1999) Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: a consensus statement of the Melanoma Genetics Consortium. J Clin Oncol 17:3245\u20133251","journal-title":"J Clin Oncol"},{"key":"20_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1529-8019.2005.00050.x","volume":"19","author":"KB Niendorf","year":"2006","unstructured":"Niendorf KB, Tsao H (2006) Cutaneous melanoma: family screening and genetic testing. Dermatol Ther 19:1\u20138","journal-title":"Dermatol Ther"},{"key":"20_CR56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mge.2003.28","volume":"57","author":"SJ Rulyak","year":"2003","unstructured":"Rulyak SJ, Kimmey MB, Veenstra DL et al (2003) Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc 57:23\u201329","journal-title":"Gastrointest Endosc"}],"container-title":["Methods in Molecular Biology","Molecular Diagnostics for Melanoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-62703-727-3_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T08:19:00Z","timestamp":1676362740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-62703-727-3_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,31]]},"ISBN":["9781627037266","9781627037273"],"references-count":56,"URL":"https:\/\/doi.org\/10.1007\/978-1-62703-727-3_20","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,31]]},"assertion":[{"value":"31 October 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}